Comparative findings between68Ga-PSMA and18F-FDG PET/CT for hepatocellular carcinoma

6Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We have reported here the case of a 69-year-old man who presented with spinal cord compression due to bone metastases as the first manifestation of hepatocellular carcinoma (HCC). For the initial staging, the patient underwent18F-fluorodeoxyglucose (FDG) positron emission tomography/ computerized tomography (PET/CT) imaging, which demonstrated mild18F-FDG uptake in the multiple expansile osteolytic bone lesions, but no remarkable atypical18F-FDG uptake in the liver lesion on low-doses CT. An additional PET/CT scan was performed to evaluate the prostate-specific membrane antigen (PSMA) expression, which has recently been reported to be a potential biological marker in a variety of tumors including HCC. High PSMA uptake was recorded in both the metastatic bone lesions and the primary liver lesion/tumor by the68Ga-PSMA PET/CT.

Cite

CITATION STYLE

APA

Erhamamcı, S., & Aslan, N. (2020). Comparative findings between68Ga-PSMA and18F-FDG PET/CT for hepatocellular carcinoma. Molecular Imaging and Radionuclide Therapy, 29(3), 135–138. https://doi.org/10.4274/mirt.galenos.2020.50455

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free